Should you buy Aurora Cannabis (ACB) stock right now?

With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (NASDAQ: ACB) stock does not look much like a screaming buy right now.

How do I see a recent viewed ACB stock ticker?

Log in to see them here or sign up to get started. Visit a quote page and your recently viewed tickers will be displayed here. ACB | Complete Aurora Cannabis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Should you buy ACB (ACB) in 2022?

In 2022, ACB's revenue was 221.34 million, a decrease of -9.75% compared to the previous year's 245.25 million. Losses were -1.72 billion, 147.2% more than in 2021. According to 2 analysts, the average rating for ACB stock is "Hold." The 12-month stock price forecast is $0.9, which is an increase of 93.09% from the latest price.

What does ACB stand for?

NASDAQ | TSX: ACB EDMONTON, AB , Sept. 19, 2023 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today anno...